Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

Center for Reproductive Rights Reopens Lawsuit Against FDA Restrictions on Emergency Contraception

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

Related Content

Issues:

Abortion, Definitions, Legal Restrictions, Other Barriers, Contraception, Emergency Contraception, Legal Restrictions

Regions:

United States

Work:

In the Courts

Type:

Uncategorized

Case Archive

For updates on this case and others, explore our case archive here.

Follow the Center

Donate Now

Join Now

02.08.2012

In the Courts Abortion United States Uncategorized

Center for Reproductive Rights Reopens Lawsuit Against FDA Restrictions on Emergency Contraception

Justin Goldberg

Share this Story

  • facebook
  • Twitter
  • linkedin
  • Email id
Center requests addition of HHS Secretary Kathleen Sebelius as defendant, seeks immediate and unrestricted OTC status

(PRESS RELEASE) Seeking immediate relief that would allow emergency contraception over-the-counter access for women of all ages, today the Center for Reproductive Rights asked a federal court to reopen the Center’s 2005 lawsuit against the Food and Drug Administration (FDA) for imposing unnecessary age restrictions on the drugs, also known as the “morning-after pill.”The Center also requested the addition of U.S. Department of Health and Human Services Secretary Kathleen Sebelius as a defendant in the reopened case for her role in recently overruling the FDA’s decision to approve Plan B One-Step for over-the-counter status in December 2011.“After 10 years of stalling and putting politics before science, it is time to bring emergency contraception out from behind the pharmacy counter,” said Nancy Northup, president and CEO for the Center for Reproductive Rights. “While we applaud the Obama Administration for recognizing that no-copay birth control is a vital preventive healthcare service, HHS’s actions on emergency contraception have been arbitrary and legally unjustifiable.” Northup also emphasized the benefits of increasing access to emergency contraception to women of all ages. Currently, levonorgestrel-based emergency contraceptives (such as Plan B One-Step) are available to women 17 and older without a prescription, with young women under 17 required to obtain a prescription from a physician. Even for women 17 and older, however, the medication is available only at pharmacies upon request and with adequate identification. If the drugs were granted unrestricted access, they could be sold at stores other than just pharmacies and identification would not be required “Some women don’t have the identification they need to get emergency contraception. Others may find their local pharmacy counters closed late at night or on weekends. They all need better access to this safe and effective method of contraception when emergencies happen,” said Northup.The new suit asks U.S. District Court Judge Edward Korman to issue a preliminary injunction that would allow all levonorgestrel-based emergency contraceptives —both the single-dose Plan B One-Step and the two-dose generic brands — to be immediately approved for unrestricted over-the-counter sale.“The FDA has continually treated emergency contraception completely different than it has any other medication,” said Suzanne Novak, senior staff attorney for the Center for Reproductive Rights and lead counsel on this case. “We are asking the court to recognize that the FDA has failed to meet its obligation to the public and make decisions based on science, rather than politics.”The Center initially filed a Citizen Petition with the FDA in 2001 on behalf of over 70 medical and public health organizations, asking the agency to grant over-the-counter status to all emergency contraceptive products available at the time. Based on the way the FDA failed to respond appropriately to both the Citizen Petition and applications from manufacturers of emergency contraception, the Center filed a lawsuit in 2005 in federal court. According to the Center’s lawsuit, by denying women of all ages access to emergency contraception without a prescription, and by failing to follow its own procedures and statutory and regulatory mandates, the FDA has violated the Administrative Procedure Act and the U.S. Constitution. 
In 2009, the federal court ordered the FDA to immediately grant over-the-counter status to Plan B for 17 year olds, and also ordered the agency to reconsider the Citizen Petition because it concluded that the agency had based its decision to restrict access to Plan B on politics rather than science. The Center filed a motion for contempt against the FDA in November 2010 for continually failing to follow that order and rule on the Citizen Petition.
 
In February 2011, Plan B One-Step’s drug manufacturer filed a supplemental new application asking the FDA to allow unrestricted over-the-counter distribution of the product. According to the FDA, the agency was poised to approve Plan B One-Step for over-the-counter, unrestricted use based on a “body of scientific findings, input from external scientific advisory committees, and data contained in the application that included studies designed to specifically address the regulatory standards for nonprescription drugs.”
 
But on December 7, 2011, Secretary Sebelius blocked that approval, asserting that the data submitted with the application “do not conclusively establish that Plan B One-Step should be made available over the counter for all girls of reproductive age.” The FDA denied the 2001 Citizen Petition a week later on the eve of the contempt motion hearing.While Judge Korman found the contempt motion moot because the FDA did finally rule on the petition—two years after it was ordered to do so—he noted that these recent events drew striking similarities to the findings in 2009 that the FDA under the Bush Administration had “acted in bad faith and in response to political pressure.” The Center filed Tummino v. Hamburg along with Andrea Costello of Florida Institutional Legal Services on behalf of the Association of Reproductive Health Professionals (ARHP), National Latina Institute for Reproductive Health, grassroots activists with National Women’s Liberation, and parents who seek over-the-counter access for their daughters.

Related Posts

Azar v. Garza Amicus Brief

Abortion,United States,In the Courts

Complaint: Falls Church Healthcare Center et al. v. Norman Oliver et al.

Abortion,United States,In the Courts

Amicus Brief: State of California et al. v. Alex M. Azar et al.

Other Barriers, Contraception,United States,In the Courts

Sign up for email updates.

The most up-to-date news on reproductive rights, delivered straight to you.

Footer Menu

  • Careers
  • Privacy Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2022)

Use of this site signifies agreement with our disclaimer and privacy policy.

Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up